OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications DOI Creative Commons

Khalid Otmani,

Rédouane Rouas,

Philippe Lewalle

и другие.

Frontiers in Immunology, Год журнала: 2022, Номер 13

Опубликована: Сен. 16, 2022

Currently, microRNAs have been established as central players in tumorigenesis, but above all, they opened an important door for our understanding of immune and tumor cell communication. This dialog is largely due to onco-miR transfer from cells the microenvironment by exosome. review outlines recent advances regarding role oncomiRs enhancing cancer how modulate cancer-related response microenvironment. MicroRNAs (miRNAs) are a type noncoding RNA that posttranscriptional regulators messenger (mRNA) translation into proteins. By regulating gene expression, miRNAs enhance or inhibit development participate several biological processes, including proliferation, invasion metastasis, angiogenesis, chemoresistance escape. Consistent with their widespread effects, categorized oncogenes (oncomiRs) suppressor (TS) miRNAs. MiRNAs promote growth, called oncomiRs, RNAs TS genes therefore overexpressed cancer. In contrast, oncogene underexpressed Endogenous regulate different cellular pathways all types. Therefore, not only key modulators also constituting microenvironments. Recently, it was shown involved intercellular Indeed, can be transferred one another where targeted expression. The primary carriers exosomes. Exosomes currently considered communication between its surrounding stromal support progression drive suppression. Exosome seen many hope developing new class therapy. aggressive characteristics deeply discusses suppressing anticancer Additionally, further mechanism oncomiR-related suppression will facilitate use biomarkers impaired antitumor function, making them ideal immunotherapy targets.

Язык: Английский

RNA delivery by extracellular vesicles in mammalian cells and its applications DOI Open Access
Killian P. O’Brien, Koen Breyne, Stefano Ughetto

и другие.

Nature Reviews Molecular Cell Biology, Год журнала: 2020, Номер 21(10), С. 585 - 606

Опубликована: Май 26, 2020

Язык: Английский

Процитировано

1434

Roles and mechanisms of exosomal non-coding RNAs in human health and diseases DOI Creative Commons
Chen Li, Yu‐Qing Ni, Hui Xu

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2021, Номер 6(1)

Опубликована: Ноя. 10, 2021

Exosomes play a role as mediators of cell-to-cell communication, thus exhibiting pleiotropic activities to homeostasis regulation. Exosomal non-coding RNAs (ncRNAs), mainly microRNAs (miRNAs), long (lncRNAs), and circular (circRNAs), are closely related variety biological functional aspects human health. When the exosomal ncRNAs undergo tissue-specific changes due diverse internal or external disorders, they can cause tissue dysfunction, aging, diseases. In this review, we comprehensively discuss underlying regulatory mechanisms exosomes in addition, explore current knowledge on roles miRNAs, lncRNAs, circRNAs health diseases, including cancers, metabolic neurodegenerative cardiovascular autoimmune infectious determine their potential implication biomarker identification therapeutic exploration.

Язык: Английский

Процитировано

282

Exosomes and breast cancer drug resistance DOI Creative Commons

Xingli Dong,

Xupeng Bai, Jie Ni

и другие.

Cell Death and Disease, Год журнала: 2020, Номер 11(11)

Опубликована: Ноя. 17, 2020

Abstract Drug resistance is a daunting challenge in the treatment of breast cancer (BC). Exosomes, as intercellular communicative vectors tumor microenvironment, play an important role BC progression. With in-depth understanding heterogeneity, emerging exosomes drug has attracted extensive attention. The functional proteins or non-coding RNAs contained secreted from and stromal cells mediate by regulating efflux metabolism, pro-survival signaling, epithelial–mesenchymal transition, stem-like property, microenvironmental remodeling. In this review, we summarize underlying associations between discuss unique biogenesis exosomes, change exosome cargo, pattern release response to treatment. Moreover, propose candidate biomarker predicting monitoring therapeutic potential target carrier reverse BC.

Язык: Английский

Процитировано

155

Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer DOI Creative Commons

K. Auxzilia Preethi,

Sushmaa Chandralekha Selvakumar, Kehinde Ross

и другие.

Molecular Cancer, Год журнала: 2022, Номер 21(1)

Опубликована: Фев. 16, 2022

Abstract Background Detecting cancer at an early stage before clinical manifestation could be effective strategy to decrease mortality. Thus, identifying liquid biopsy biomarkers with high efficacy a promising approach for non-invasive diagnosis of cancer. Main text Liquid biopsies are increasingly used as supplement biopsy, it enables disease progression detected months and radiographic confirmation. Many bodily fluids contain exosomal microRNAs (miRNAs) which provide new class minimally invasive due the stability miRNAs in exosomes. In this review, we mainly focused on (liquid biopsy) prognosis various cancers. Conclusion Exosomal can diagnostic that unique insights more dynamic perspective therapeutic responses malignancies. Therefore, development novel sensitive technologies exploit should priority management.

Язык: Английский

Процитировано

140

Tumor-Derived Exosomes in Immunosuppression and Immunotherapy DOI Creative Commons
Wioletta Olejarz, Agnieszka Dominiak,

Aleksandra Żołnierzak

и другие.

Journal of Immunology Research, Год журнала: 2020, Номер 2020, С. 1 - 11

Опубликована: Май 22, 2020

Tumor-derived exosomes (TEX) are involved in cancer development, metastasis, and disease progression. They can modulate angiogenesis to elevate the malignant degree of tumor cells. TEX carry immunosuppressive factors affecting antitumor activities immune Tumor cells as well secrete immunologically active which affect intercellular communication, antigen presentation, activation cells, surveillance. Cell proliferation response suppression create a favorable microenvironment for tumor. inhibit cell proliferation, induce apoptosis activated CD8+ Teffs, suppress NK activity, interfere with monocyte differentiation, promote Treg MDSC expansion. Exosomes may also contribute development drug resistance therapy. An important role modulating sensitivity immunotherapy is promising area research make therapy more successful.

Язык: Английский

Процитировано

123

Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer DOI Creative Commons
Eleni‐Kyriaki Vetsika,

Aristeidis Koukos,

Athanasios Κotsakis

и другие.

Cells, Год журнала: 2019, Номер 8(12), С. 1647 - 1647

Опубликована: Дек. 15, 2019

Myeloid-derived suppressor cells (MDSCs) constitute a vast population of immature myeloid implicated in various conditions. Most notably, their role cancer is great complexity. They exert immunosuppressive functions like hampering immunity mediated by T lymphocytes and natural killer cells, while simultaneously they can recruit regulatory to further promote immunosuppression, thus shielding tumor against the immune defenses. In addition, were shown support invasion metastasis inducing vascularization. Yet again, order angiogenic activities, do have at disposal variety occasionally overlapping mechanisms, mainly driven VEGF/JAK/STAT signaling. this concept, risen be rather attractive target for therapies, including depletion or maturation, so as overcome suppress activity. Even though, many studies been conducted better understand these there much done yet. This article hopes shed some light on paradoxal complexity elucidating key features MDSCs relation immunosuppression and, most importantly, vascularization processes, along with current therapeutic options cancer, MDSC depletion.

Язык: Английский

Процитировано

103

Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression DOI Creative Commons
Yingying Xing,

Guojing Ruan,

Haiwei Ni

и другие.

Frontiers in Immunology, Год журнала: 2021, Номер 12

Опубликована: Май 18, 2021

MiRNA is a type of small non-coding RNA, by regulating downstream gene expression that affects the progression multiple diseases, especially cancer. can participate in biological processes tumor, including proliferation, invasion and escape, exhibit tumor enhancement or inhibition. The immune microenvironment contains numerous cells. These cells include lymphocytes with suppressor effects such as CD8+ T natural killer cells, well some tumor-promoting immunosuppressive functions, regulatory myeloid-derived affect function which turn modulates Investigating role miRNA will help elucidate specific mechanisms interaction between may facilitate use predictor disorders progression. This review summarizes multifarious roles through regulation microenvironment, provides guidance for development drugs to treat tumors an auxiliary means immunotherapy.

Язык: Английский

Процитировано

71

Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation DOI Creative Commons
Muhammad Javed Iqbal, Zeeshan Javed, Jesús Herrera‐Bravo

и другие.

Cancer Cell International, Год журнала: 2022, Номер 22(1)

Опубликована: Ноя. 15, 2022

Abstract Recent technological advances in nanoscience and material designing have led to the development of point-of-care devices for biomolecule sensing cancer diagnosis. In situ portable bedside, diagnosis can effectively improve patient’s clinical outcomes reduce mortality rate. Detection exosomal RNAs by immuno-biochip with increased sensitivity specificity diagnose has raised understanding tumor microenvironment many other technology-based biosensing hold great promise innovations conquer unbeatable fort metastasis. Electrochemical biosensors are most sensitive category detection sensors significantly low concentrations down atomic level. this sense, review addresses recent developing significant biological that believed better potential than existing facilities.

Язык: Английский

Процитировано

51

Small extracellular vesicles: from mediating cancer cell metastasis to therapeutic value in pancreatic cancer DOI Creative Commons
Wenjie Zhang,

Juan Xing,

Tian Liu

и другие.

Cell Communication and Signaling, Год журнала: 2022, Номер 20(1)

Опубликована: Янв. 3, 2022

Pancreatic cancer is a highly malignant tumor and, extremely difficult to diagnose and treat. Metastasis one of the critical steps in development uses cell communication mediate changes microenvironment. Small extracellular vesicles (sEVs)-carry proteins, nucleic acids other bioactive substances, are important medium for between cells. There two primary sVEs-mediated metastasis: pancreatic cells their surrounding microenvironment; distant organ organs that promotes angiogenesis, reshaping matrix, forming immunosuppressive environment ways form appropriate pre-metastasis niche. Here, we explore mechanism localization metastasis use sEVs as early biomarkers detection treatment cancer. Video Abstract.

Язык: Английский

Процитировано

49

Recognition and analysis of biomarkers in tumor microenvironments based on promising molecular imprinting strategies with high selectivity DOI

Jia-Yuan He,

Qin Li,

Hui-Xian Xu

и другие.

TrAC Trends in Analytical Chemistry, Год журнала: 2023, Номер 162, С. 117033 - 117033

Опубликована: Март 22, 2023

Язык: Английский

Процитировано

32